These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9064220)

  • 1. [Immunophenotyping in the diagnosis of non-Hodgkin lymphomas: a literature review].
    Rauh S; Duhem C; Mahassen P; Ries F; Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 1996; 133(2):27-33. PubMed ID: 9064220
    [No Abstract]   [Full Text] [Related]  

  • 2. [The clinical significance of the immunological phenotype in non-Hodgkin's lymphomas].
    Golenkov AK; Miterev GIu; Popov VM; Shakher AL
    Ter Arkh; 1995; 67(7):30-2. PubMed ID: 7482301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunophenotyping of leukaemias and non-Hodgkin's lymphomas. Immunological markers and their CD codes.
    van Dongen JJ; Adriaansen HJ; Hooijkaas H
    Neth J Med; 1988 Dec; 33(5-6):298-314. PubMed ID: 3265488
    [No Abstract]   [Full Text] [Related]  

  • 4. Distinguishing between immunophenotype and genotype in non-Hodgkin's lymphomas.
    Gascoyne RD
    Curr Hematol Rep; 2003 Nov; 2(6):443-4. PubMed ID: 14561386
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunophenotyping of lymphomas and leukemias in paraffin-embedded tissues.
    Perkins SL; Kjeldsberg CR
    Am J Clin Pathol; 1993 Apr; 99(4):362-73. PubMed ID: 8475901
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
    Glasová M; Koníková E; Stasáková J; Babusíková O
    Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunobiologic correlates of prognosis in lymphoma.
    Grogan TM; Miller TP
    Semin Oncol; 1993 Oct; 20(5 Suppl 5):58-74. PubMed ID: 8211208
    [No Abstract]   [Full Text] [Related]  

  • 8. An expert system for the interpretation of flow cytometric immunophenotyping data.
    Diamond LW; Nguyen DT; Jouault H; Imbert M; Sultan C
    J Clin Comput; 1994 Apr; 22(2-3):50-8. PubMed ID: 10172182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aggressive lymphomas: a convenient concept or an anatomo-pathological reality?].
    Pileri SA; Fraternali-Orcioni G; Ascani S; Piccioli M; Poggi S; Piccaluga PP; Leoncini L; Falini B
    Pathologica; 2000 Jun; 92(3):145-61. PubMed ID: 10902425
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunophenotyping of acute leukaemias and non-Hodgkin's lymphoma--review of ongoing consensus protocols.
    Höffkes HG; Brittinger G; Franke A
    Eur J Med Res; 1996 Jun; 1(9):433-8. PubMed ID: 9438140
    [No Abstract]   [Full Text] [Related]  

  • 11. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
    Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
    Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunophenotyping in the differential diagnosis of malignant non-hodgkin's lymphomas].
    Dzembak TM; Gurkalo VK; Gershanovich ML
    Vopr Onkol; 1996; 42(5):63-6. PubMed ID: 9064906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-Hodgkin lymphoma: a critical review of 307 cases with technical suggestions.
    Zeppa P; Marino G; Troncone G; Fulciniti F; De Renzo A; Picardi M; Benincasa G; Rotoli B; Vetrani A; Palombini L
    Cancer; 2004 Feb; 102(1):55-65. PubMed ID: 14968418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The different expression of key-molecules allows the easy subclassification of Hodgkin's lymphoma cases as well as their distinction from non-Hodgkin's lymphomas.
    Pileri SA; Marafioti T; Pozzobon M; Sabattini E; Ascani S; Mancini C; Piccioli M; Hansmann ML; Delsol G; Mason DY
    Pathologica; 2003 Oct; 95(5):227. PubMed ID: 14988978
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow involvement by hodgkin and non-hodgkin lymphomas.
    Zhang QY; Foucar K
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):873-902. PubMed ID: 19577173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of CD71 expression by flow cytometry for differentiating indolent from aggressive CD10+ B-cell lymphomas.
    Wu JM; Borowitz MJ; Weir EG
    Am J Clin Pathol; 2006 Jul; 126(1):39-46. PubMed ID: 16753591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-needle aspiration cytology combined with flow cytometry immunophenotyping is a rapid and accurate approach for the evaluation of suspicious superficial lymphoid lesions.
    Mathiot C; Decaudin D; Klijanienko J; Couturier J; Salomon A; Dumont J; Vielh P
    Diagn Cytopathol; 2006 Jul; 34(7):472-8. PubMed ID: 16783780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histopathology of leukaemic non-Hodgkin's lymphoma in bone marrow].
    Buhr T; Länger F; Schlué J; V Wasielewski R; Kreipe H
    Pathologe; 2002 Nov; 23(6):438-47. PubMed ID: 12436297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas.
    Mazur G; Hałoń A; Wróbel T; Jeleń M; Kuliczkowski K
    Neoplasma; 2004; 51(3):159-63. PubMed ID: 15254666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.